August 24, 2025Open Access

Alleviating negative symptoms in schizophrenia using a Virtual Reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study

View Full Paper

Ask AI

Bookmark

Authors

VDValentin M. DonathCopenhagen University Hospital EREmma Slebsager Ries LMLise Sandvig MariegaardUniversity of Copenhagen

Discussion

Member takes

Implication

Randomised pilot study tests feasibility and efficacy of VR therapy targeting negative symptoms in schizophrenia, suggesting potential for improved treatment options.

Key Points

Significant improvement in negative symptoms is expected with the VR therapy targeting social reward learning.
The study focuses on 30 outpatients with schizophrenia spectrum disorders, assessing clinical outcomes and quality of life.
This randomised, assessor-blind trial involves direct comparisons with treatment as usual over 10 sessions.
This virtual reality approach may enable better management of negative symptoms, addressing treatment gaps in schizophrenia.

Cite This Study

Donath et al. (2025) studied this question.

synapsesocial.com/papers/68af79ab7567bf4f94ff189d https://doi.org/10.1101/2025.08.20.25334133

View Full Paper

Ask AI

Bookmark

Implication

Randomised pilot study tests feasibility and efficacy of VR therapy targeting negative symptoms in schizophrenia, suggesting potential for improved treatment options.

Alleviating negative symptoms in schizophrenia using a Virtual Reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study

Discussion

Member takes

Implication

Key Points

Cite This Study

Alleviating negative symptoms in schizophrenia using a Virtual Reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider